Rhamnose-Containing Compounds: Biosynthesis and Applications.

Area of Science:

• Biochemistry
• Microbiology
• Drug Discovery

Background:

• Rhamnose-associated molecules are unique to bacteria, presenting therapeutic opportunities.
• These compounds are investigated for antibacterial applications and tumor immunotherapy.

Purpose of the Study:

• To review the biosynthetic pathways of key rhamnose donors: deoxythymidinediphosphate-L-rhamnose (dTDP-Rha), uridine diphosphate-rhamnose (UDP-Rha), and guanosine diphosphate rhamnose (GDP-Rha).
• To discuss the functions and crystal structures of enzymes involved in rhamnose biosynthesis.
• To explore the roles of rhamnosyltransferases from various bacterial species and their application in disease treatment.

Main Methods:

• Review of literature on rhamnose donor biosynthesis pathways and associated enzymes.
• Discussion of rhamnosyltransferases from key bacterial species like *Geobacillus stearothermophilus*, *Saccharopolyspora spinosa*, *Mycobacterium tuberculosis*, *Pseudomonas aeruginosa*, and *Streptococcus pneumoniae*.
• Analysis of traditional methods for enzyme function verification, including gene knockout and radiolabeled substrates.

Main Results:

• Deoxythymidinediphosphate-L-rhamnose (dTDP-Rha) is the most prevalent rhamnose donor, synthesized by four enzymes: RmlA, RmlB, RmlC, and RmlD.
• The study highlights limitations in characterizing enzymatic reaction products using conventional methods.
• The review provides insights into the enzymatic machinery and potential therapeutic applications of rhamnose-containing compounds.

Conclusions:

• Understanding rhamnose biosynthesis pathways and enzyme functions is crucial for developing novel antibacterial agents and cancer immunotherapies.
• Further research is needed to overcome challenges in characterizing enzymatic products for more effective drug development.
• Rhamnose-containing compounds hold significant potential for future therapeutic interventions in infectious diseases and oncology.